The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis
Alberto Riñon1, Mandy Buch2, Derek Holley2, Elisabetta Verdun11Merck Serono S.A.– Geneva, Switzerland, a branch of Merck Serono S.A., Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany; 2GfK Healthcare, London, UKBackground: Treatment of multiple sclerosis (MS) with disease-modifying drugs (DMDs) can reduce r